Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Delineating and eradicating cardiovascular inflammageing

Ziel

Atherosclerotic cardiovascular disease remains a leading global cause of morbidity and mortality, driven by inflammageing: a chronic, age-related inflammatory state accelerating atherosclerosis via epigenetic dysregulation in bone marrow immune cells, particularly hematopoietic stem and progenitor cells (HSPCs). Despite therapeutic advances, the precise mechanisms linking inflammageing to atherosclerosis remain underexplored, necessitating innovative approaches to address this escalating health burden in aging populations.

The DEFLAME Program, a cross-disciplinary bioengineering initiative led by Prof. Dr. Willem Mulder, is aimed at delineating the heterogeneous mechanisms of cardiovascular inflammageing across bone marrow niches to guide development of precision mRNA immunotherapy for this insidious process. Leveraging MarrowMap, a novel quantitative tool to map immune cell metabolism across multiple bone marrow niches in mouse models, and our proprietary apolipoprotein nanoparticle (aNP) mRNA delivery platform, DEFLAME integrates nanomedicine, nuclear medicine, hematopoiesis, cardiovascular immunology and multi-omics to achieve two objectives:

O1 To longitudinally and spatially characterize inflammageing in atherosclerosis-accelerated immune aging, myocardial infarction, and intermittent cholesterol exposure models.

O2 To develop aNP-mRNA-based cytokine and checkpoint-directed immunotherapies targeting myeloid (progenitor) cells, with translational evaluation in human cell models.

By combining expertise in nanomedicine, innate immunity, and cardiovascular disease, this high-risk, high-gain ERC Advanced Grant Program seeks to reshape our understanding of immune aging and deliver innovative immunotherapeutics with potential applications beyond cardiovascular disease, including cancer and neurodegenerative disorders, fostering breakthroughs for healthy aging.

Wissenschaftliches Gebiet (EuroSciVoc)

Dieses Projekt wurde noch nicht bei EuroSciVoc klassifiziert.
Schlagen Sie die Wissenschaftsbereiche vor, die Ihrer Einschätzung nach besonders relevant sind, und helfen Sie uns, unseren Klassifizierungsdienst zu verbessern.

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Finanzierungsplan

HORIZON-ERC - HORIZON ERC Grants

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) ERC-2025-ADG

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Gastgebende Einrichtung

TECHNISCHE UNIVERSITEIT EINDHOVEN
Netto-EU-Beitrag
€ 1 550 763,75
Adresse
GROENE LOPER 3
5612 AE Eindhoven
Niederlande
Region
Zuid-Nederland Noord-Brabant Zuidoost-Noord-Brabant
Aktivitätstyp
Higher or Secondary Education Establishments
Links
Gesamtkosten
Keine Daten

Begünstigte (2)